NewEdge Advisors’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $714K | Buy |
25,142
+1,305
| +5% | +$37.1K | ﹤0.01% | 1479 |
|
|
2025
Q1 | $704K | Buy |
23,837
+4,410
| +23% | +$130K | ﹤0.01% | 1389 |
|
|
2024
Q4 | $565K | Buy |
19,427
+1,412
| +8% | +$41.1K | ﹤0.01% | 1469 |
|
|
2024
Q3 | $827K | Buy |
18,015
+7,048
| +64% | +$324K | 0.01% | 1188 |
|
|
2024
Q2 | $448K | Buy |
+10,967
| New | +$448K | ﹤0.01% | 1476 |
|
|
2023
Q1 | – | Sell |
-49
| Closed | -$1.09K | – | 4001 |
|
|
2022
Q4 | $1.09K | Buy |
+49
| New | +$1.09K | ﹤0.01% | 3014 |
|